M&A Deal Summary

LetsGetChecked Acquires Veritas Intercontinental

On March 29, 2022, LetsGetChecked acquired life science company Veritas Intercontinental from Charme Capital Partners and Amadeus Capital Partners

Acquisition Highlights
  • This is LetsGetChecked’s 2nd transaction in the Life Science sector.
  • This is LetsGetChecked’s 1st transaction in Spain.

M&A Deal Summary

Date 2022-03-29
Target Veritas Intercontinental
Sector Life Science
Buyer(s) LetsGetChecked
Sellers(s) Charme Capital Partners
Amadeus Capital Partners
Deal Type Add-on Acquisition

Target

Veritas Intercontinental

Madrid, Spain
Veritas Intercontinental is a provider of whole genome and exome sequencing based analyses and genetic services for maternal-fetal medicine through large hospitals, specialized clinics and medical distributors. Veritas Intercontinental was founded in 2018 and is based in Madrid, Spain.

Search 215,058 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

LetsGetChecked

New York, New York, United States

Category Company
Founded 2015
Sector Healthcare Services
DESCRIPTION

LetsGetChecked is a healthcare solutions company that allows customers to manage their health from home, providing direct access to telehealth services, pharmacy, and at-home diagnostics for a wide range of health conditions including Sexual Health, Cholesterol, Diabetes, Thyroid, Coronavirus (COVID-19), and more. LetsGetChecked was founded in 2015 and is based in New York, New York.


DEAL STATS #
Overall 3 of 3
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 3 of 3
Country: Spain M&A 1 of 1
Year: 2022 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-03-29 Veritas Genetics

Danvers, Massachusetts, United States

Veritas Genetics is a provider of consumer genetics and whole genome sequencing services. Veritas Genetics was established in 2014 and is based in Danvers, Massachusetts.

Buy -

Seller(S) 2

SELLER

Charme Capital Partners

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2002
PE ASSETS 1.0B EUR
Size Large
Type Sector Agnostic
DESCRIPTION

Charme Capital Partners is a private equity firm focused on acquiring and investing mid-sized European companies valued from €100 to €500 million. The Firm has a particular interest in companies located in the UK, Spain, and Italy exhibiting strong growth prospects and operating in a range of business sectors. Charme Capital Partners was established in 2003 and has offices in London, Milan, and Madrid.


DEAL STATS #
Overall 8 of 10
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 3 of 3
Country: Spain M&A 4 of 4
Year: 2022 M&A 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-03-01 Prism Medical UK

Wakefield, United Kingdom

Prism Medical UK is a provider of specialist equipment for the safer moving and handling of the mobility disadvantaged within their homes, long-term care, or acute environment. The company develops and supplies moving, handling, and bathing equipment, as well as working closely with the clients and caregivers who use them. Prism Medical UK is based in Wakefield, United Kingdom.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-10-27 Tema Sinergie

Faenza, Italy

Tema Sinergie is highly-specialized sectors of isolators for nuclear medicine and the production of biotech pharmaceuticals. Tema Sinergie was founded in 1985 and is based in Faenza, Italy.

Buy -
SELLER

Amadeus Capital Partners

Investor Investor Investor Investor Investor


Category Venture Capital Firm
Founded 1997
PE ASSETS 1.3B USD
Size Large
Type Sector Focused
DESCRIPTION

Amadeus Capital Partners is an early late-stage investor in high growth European technology companies. Specific areas of interest include AI & machine learning, online consumer services, cybersecurity, digital health and medical technology, digital media, enterprise SaaS, fintech, and insurtech. Amadeus Capital Partners was formed in 1997 and is based in London, United Kingdom.


DEAL STATS #
Overall 16 of 26
Sector: Life Science M&A 2 of 3
Type: Add-on Acquisition M&A Deals 13 of 20
Country: Spain M&A 2 of 2
Year: 2022 M&A 2 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-03-16 Exonar

Reading, United Kingdom

Exonar is a data discovery software to protect and power organizations and the people they serve. Exonar specializes in next-generation data loss prevention (DLP). Exonar was founded in 2007 and is based in Reading, England.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-04-12 Five AI

Cambridge, United Kingdom

Five AI provides autonomous vehicle software and development platforms for OEMs and transportation operators, focusing on safety assurance, simulation, and validation of self-driving systems. Five AI was founded in 2015 and is based in Cambridge, United Kingdom.

Sell -